-
IMPACT OF THE FDA DRUG SAFETY COMMUNICATIONONCODEINE ANDTRAMADOLPRESCRIBING INPEDIATRICDENTALCARE:EVIDENCE FROMNATIONALLY SOURCEDCLAIMSDATA
Mar 18, 2026, 21:38 PM -
DISPARITIES IN HEALTH CARE EXPENDITURES AMONG US PATIENTS WITH OPIOID USE DISORDER USING BUPRENORPHINE VERSUS METHADONE
Mar 18, 2026, 21:38 PM -
ASSESSING CONCENTRATION IN THE MONOCLONAL ANTIBODY INNOVATION MARKET: A PATENT-BASED STUDY
Mar 18, 2026, 21:38 PM -
CARBON AVOIDANCE: A COMPARISON OF SURGICAL APPROACHES
Mar 18, 2026, 21:38 PM -
POPULATION CHARACTERISTICS AND CLINICAL MEDICATION PATTERNS OF COUGH PATIENTS IN CHINA BASED ON REGIONAL REAL-WORLDDATA
Mar 18, 2026, 21:38 PM -
AUTOMATION OF SYSTEMATIC REVIEWS WITH LARGE LANGUAGE MODELS
Mar 18, 2026, 21:38 PM -
COMMERCIAL PAYER COVERAGE OF BIOSIMILARS: 2017-2024
Mar 18, 2026, 21:38 PM -
FROM INCORPORATION TO IMPACT: REAL-WORLD BUDGET ADVANTAGE OF CLADRIBINE IN MULTIPLE SCLEROSIS WITHIN A BRAZILIAN PRIVATE HEALTH PLAN
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF AN AUTOMATED DELIVERY ROBOT PROGRAM TO REDUCE NURSING TRANSPORT BURDEN IN AN INTENSIVE CARE UNIT: A HOSPITAL-PROVIDER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
EFFICACY OF PANITUMUMAB VS. CETUXIMAB PLUS CHEMOTHERAPY IN RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK: AN ANCHORED MATCHING-ADJUSTED INDIRECT COMPARISON
Mar 18, 2026, 21:38 PM -
COMPARING LLM-BASED TO EXPERT-CURATED EXTRACTION FOR BIOMARKER ATTRIBUTES IN LUNG AND BREAST CANCER
Mar 18, 2026, 21:38 PM -
CARDIOVASCULAR RISK AND COMORBIDITY BURDEN IN JAPANESE PATIENTS WITH MYASTHENIA GRAVIS A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
HOW PAYERS READ THE TEA LEAVES: ECONOMIC AND FORMULARY SIGNALS FROM IRA AND MFN?
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF PREVENTING RECURRENT STROKE THROUGH OCCLUDER DEVICE SELECTION IN PATIENTS WITH PATENT FORAMEN OVALE: A PERSPECTIVE FROM US HOSPITALS
Mar 18, 2026, 21:38 PM -
BRIDGING EU AND NATIONAL HTA - BULGARIAN ONCOLOGISTS’ PERCEPTIONS OF THE JOINT CLINICAL ASSESSMENT
Mar 18, 2026, 21:38 PM -
HYPERTENSION CONTROL IN TREATED U.S. CANCER SURVIVORS UNDER THE 2017 ACC/AHA GUIDELINE: AN ANALYSIS OF NHANES 2011-2023
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN GLP-1 RECEPTOR AGONIST INITIATION AND ALCOHOL USE DISORDER AND ALCOHOL-RELATED MEDICAL CONDITIONS IN A U.S. ADMINISTRATIVE CLAIMS DATABASE
Mar 18, 2026, 21:38 PM -
ADHERENCE TO ENDOCRINE THERAPY IN BREAST CANCER: A DETERMINANT OF OUTCOMES
Mar 18, 2026, 21:38 PM -
ROBOTIC SURGERY IN HUNGARY (2022-2025): EXPANSION, CASE-MIX DYNAMICS, AND PROVIDER CONCENTRATION
Mar 18, 2026, 21:38 PM -
REAL-WORLD DATA ANALYSIS OF ONCOLOGICAL DRUG FUNDING AND ACCESS HETEROGENEITY IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
Mar 18, 2026, 21:38 PM
